Department of Microbiology, Research Institute for Antimicrobial Resistance, Kosin University College of Medicine, Busan, South Korea.
Department of Microbiology and Immunology, Indiana University School of Medicine-Northwest, Gary, Indiana, USA.
J Bacteriol. 2022 Jun 21;204(6):e0001822. doi: 10.1128/jb.00018-22. Epub 2022 May 12.
The Gram-positive pathogen Staphylococcus aureus is the only bacterium known to synthesize arginine from proline via the arginine-proline interconversion pathway despite having genes for the well-conserved glutamate pathway. Since the proline-arginine interconversion pathway is repressed by CcpA-mediated carbon catabolite repression (CCR), CCR has been attributed to the arginine auxotrophy of S. aureus. Using ribose as a secondary carbon source, here, we demonstrate that S. aureus arginine auxotrophy is not due to CCR but due to the inadequate concentration of proline degradation product. Proline is degraded by proline dehydrogenase (PutA) into pyrroline-5-carboxylate (P5C). Although the PutA expression was fully induced by ribose, the P5C concentration remained insufficient to support arginine synthesis because P5C was constantly consumed by the P5C reductase ProC. When the P5C concentration was artificially increased by either PutA overexpression or deletion, S. aureus could synthesize arginine from proline regardless of carbon source. In contrast, when the P5C concentration was reduced by overexpression of , it inhibited the growth of the deletion mutant without arginine. Intriguingly, the ectopic expression of the glutamate pathway enzymes converted S. aureus into arginine prototroph. In an animal experiment, the arginine-proline interconversion pathway was not required for the survival of S. aureus. Based on these results, we concluded that S. aureus does not synthesize arginine from proline under physiological conditions. We also propose that arginine auxotrophy of S. aureus is not due to the CcpA-mediated CCR but due to the inactivity of the conserved glutamate pathway. Staphylococcus aureus is a versatile Gram-positive human pathogen infecting various human organs. The bacterium's versatility is partly due to efficient metabolic regulation via the carbon catabolite repression system (CCR). S. aureus is known to interconvert proline and arginine, and CCR represses the synthesis of both amino acids. However, when CCR is released by a nonpreferred carbon source, S. aureus can synthesize proline but not arginine. In this study, we show that, in S. aureus, the intracellular concentration of pyrroline-5-carboxylate (P5C), the degradation product of proline and the substrate of proline synthesis, is too low to synthesize arginine from proline. These results call into question the notion that S. aureus synthesizes arginine from proline.
革兰氏阳性病原体金黄色葡萄球菌是唯一已知能够通过精氨酸-脯氨酸相互转化途径将脯氨酸转化为精氨酸的细菌,尽管它具有保守的谷氨酸途径的基因。由于 CcpA 介导的碳分解代谢物阻遏(CCR)抑制了脯氨酸-精氨酸相互转化途径,因此 CCR 被归因于金黄色葡萄球菌的精氨酸营养缺陷型。在这里,我们使用核糖作为辅助碳源,证明金黄色葡萄球菌的精氨酸营养缺陷型不是由于 CCR 引起的,而是由于脯氨酸降解产物的浓度不足。脯氨酸被脯氨酸脱氢酶(PutA)降解为吡咯啉-5-羧酸(P5C)。尽管核糖完全诱导了 PutA 的表达,但由于 P5C 不断被 P5C 还原酶 ProC 消耗,因此 P5C 的浓度仍然不足以支持精氨酸的合成。当通过过表达 PutA 或缺失来人为增加 P5C 浓度时,金黄色葡萄球菌可以从脯氨酸合成精氨酸,而与碳源无关。相比之下,当通过过表达 来降低 P5C 浓度时,它会抑制没有精氨酸的 缺失突变体的生长。有趣的是,谷氨酸途径酶的异位表达使金黄色葡萄球菌变成精氨酸原养型。在动物实验中,精氨酸-脯氨酸相互转化途径对于金黄色葡萄球菌的存活不是必需的。基于这些结果,我们得出结论,在生理条件下,金黄色葡萄球菌不从脯氨酸合成精氨酸。我们还提出,金黄色葡萄球菌的精氨酸营养缺陷型不是由于 CcpA 介导的 CCR 引起的,而是由于保守的谷氨酸途径失活引起的。金黄色葡萄球菌是一种多功能的革兰氏阳性人类病原体,感染各种人体器官。该细菌的多功能性部分归因于通过碳分解代谢物阻遏系统(CCR)进行有效的代谢调节。金黄色葡萄球菌已知可以将脯氨酸和精氨酸相互转化,并且 CCR 抑制这两种氨基酸的合成。然而,当非首选碳源释放 CCR 时,金黄色葡萄球菌可以合成脯氨酸但不能合成精氨酸。在这项研究中,我们表明,在金黄色葡萄球菌中,吡咯啉-5-羧酸(P5C)的细胞内浓度太低,无法从脯氨酸合成精氨酸,脯氨酸是脯氨酸的降解产物和脯氨酸合成的底物。这些结果质疑了金黄色葡萄球菌从脯氨酸合成精氨酸的观点。